Current Respiratory Medicine Reviews
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 3
Author(s): Peter A. Ward
Affiliation:
Export Options
About this article
Cite this article as:
Ward A. Peter , Meet Our Editorial Board Member, Current Respiratory Medicine Reviews 2018; 14 (3) . https://dx.doi.org/10.2174/1573398X1403190107124436
DOI https://dx.doi.org/10.2174/1573398X1403190107124436 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in Tissue and Organ Replacement
Current Stem Cell Research & Therapy Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
CNS & Neurological Disorders - Drug Targets Milk Fat Globule Epidermal Growth Factor VIII Signaling in Arterial Wall Remodeling
Current Vascular Pharmacology The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design Using Small Molecule GSK3β Inhibitors to Treat Inflammation
Current Medicinal Chemistry Evaluation of Pharmacological Treatment Strategies in Traumatic Brain Injury
Current Pharmaceutical Design Association between Increased Bcl-2, Fas and FasL Levels and Inflammation Extent in Labial Salivary Glands During Primary Sjögren's Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P)
Recent Patents on Inflammation & Allergy Drug Discovery The Role of Obesity in Cardiomyopathy and Nephropathy
Current Pharmaceutical Design Diacerein-Thymol Prodrug: <i>In Vivo</i> Release and Pharmacological Screening in Experimental Models of Osteoarthritis in Wistar Rats
Inflammation & Allergy - Drug Targets (Discontinued) Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted Drugs
Current Molecular Pharmacology Stat3 Orchestrates Tumor Development and Progression: The Achilles Heel of Head and Neck Cancers?
Current Cancer Drug Targets Effects of Sublingual Immunotherapy on Allergic Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Closing in on Biliary Atresia
Current Pediatric Reviews Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Design of a Peptide Inhibitor of Tyrosine Kinase 2
Protein & Peptide Letters Synthesis and Biological Evaluation of Scutellaria Flavone Cyclaneaminol Mannich Base Derivatives as Novel CDK1 Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Recent Patents on Oxidative Stress-Related Biomarkers in Chronic Heart Failure: The Central Role of Endothelium and Myeloperoxidase
Recent Patents on Biomarkers Vitamin D and Metabolic Syndrome: Is There a Link?
Current Pharmaceutical Design Novel Therapeutic Approaches and Treatment Targets for Psoriatic Arthritis
Current Pharmaceutical Biotechnology